• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用标准术后组织学评估的基底细胞癌手术治疗

Surgical treatment of basal cell carcinomas using standard postoperative histological assessment.

作者信息

Walker Patrick, Hill Dudley

机构信息

Department of Dermatology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.

出版信息

Australas J Dermatol. 2006 Feb;47(1):1-12. doi: 10.1111/j.1440-0960.2006.00216.x.

DOI:10.1111/j.1440-0960.2006.00216.x
PMID:16405477
Abstract

SUMMARY Surgical treatment of basal cell carcinomas using postoperative histological assessment is routinely practised in Australia. The efficacy of the procedure depends on key decisions made by the surgeon. The first is case selection that requires an understanding of the limitations of the procedure. The tumour border is then identified and a margin added. The margin selected should achieve the desired balance between incomplete excision rate and mean tissue sacrifice. There is an inverse relationship between these parameters; achieving a 5% incomplete excision rate requires a mean tissue sacrifice of over 4 mm. Factors affecting margin selection are discussed, unfortunately none allows a dramatic reduction in mean tissue sacrifice. The final decision involves interpreting and acting on the histological examination of the excised specimen. Tumour recurrence is rare (less than 2% at 5 years) if the tumour is clear of the surgical margin. The visualized histological margin required to ensure complete excision varies with histological technique and tumour properties. Routine reporting of histological margin in millimetres or horizontal sectioning is recommended. Tumour recurrence averages 38% when the histological margin is involved. The merits of careful clinical follow up of incompletely excised tumours or immediate re-excision are discussed.

摘要

摘要 在澳大利亚,采用术后组织学评估进行基底细胞癌的外科治疗是常规做法。该手术的疗效取决于外科医生做出的关键决策。首先是病例选择,这需要了解该手术的局限性。然后确定肿瘤边界并增加切缘。所选切缘应在不完全切除率和平均组织牺牲之间达到理想平衡。这些参数之间存在反比关系;要实现5%的不完全切除率,平均组织牺牲需超过4毫米。文中讨论了影响切缘选择的因素,遗憾的是,没有一个因素能大幅降低平均组织牺牲。最后的决策涉及对切除标本的组织学检查结果进行解读并据此采取行动。如果肿瘤远离手术切缘,肿瘤复发很少见(5年时低于2%)。确保完全切除所需的可见组织学切缘因组织学技术和肿瘤特性而异。建议常规报告以毫米为单位的组织学切缘或水平切片情况。当组织学切缘受累时,肿瘤复发平均为38%。文中讨论了对不完全切除肿瘤进行仔细临床随访或立即再次切除的优点。

相似文献

1
Surgical treatment of basal cell carcinomas using standard postoperative histological assessment.采用标准术后组织学评估的基底细胞癌手术治疗
Australas J Dermatol. 2006 Feb;47(1):1-12. doi: 10.1111/j.1440-0960.2006.00216.x.
2
Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data.基底细胞癌的福尔马林固定组织莫氏手术(慢速莫氏手术):5年随访数据
Br J Dermatol. 2009 Mar;160(3):573-80. doi: 10.1111/j.1365-2133.2008.09021.x. Epub 2009 Jan 28.
3
Basal cell carcinoma histological clearance margins: an analysis of 1539 conventionally excised tumours. Wider still and deeper?基底细胞癌的组织学切缘:对1539例传统切除肿瘤的分析。还要更宽更深吗?
J Plast Reconstr Aesthet Surg. 2007;60(1):41-7. doi: 10.1016/j.bjps.2006.06.009. Epub 2006 Sep 1.
4
[The margin of safety and depth of excision in surgical treatment of basalioma. Use of 3-dimensional histologic study of 2,016 tumors].[基底细胞瘤外科治疗的安全切缘与切除深度。2016例肿瘤的三维组织学研究应用]
Hautarzt. 1989 Nov;40(11):693-700.
5
Mohs micrographic surgery for the management of nonmelanoma skin cancers.用于治疗非黑色素瘤皮肤癌的莫氏显微外科手术。
Facial Plast Surg Clin North Am. 2009 Aug;17(3):325-35. doi: 10.1016/j.fsc.2009.06.001.
6
An assessment of incomplete facial Basal cell carcinoma excision.面部基底细胞癌不完全切除的评估。
J Coll Physicians Surg Pak. 2005 Mar;15(3):149-51.
7
[Surgical treatment of basaliomas with calculated safety margin and control of the histologic borders. Experiences with 355 tumors].[基底细胞癌的手术治疗:计算安全切缘并控制组织学边界。355例肿瘤的经验]
Hautarzt. 1984 Jun;35(6):303-7.
8
Surgical margin marking for high-risk basal cell carcinomas of the cephalic region: a single-centre experience.头颈部高危基底细胞癌的手术切缘标记:单中心经验。
G Ital Dermatol Venereol. 2011 Apr;146(2):79-84.
9
Basal cell carcinomas: do they need to be followed up?基底细胞癌:它们需要随访吗?
J R Coll Surg Edinb. 1994 Apr;39(2):109-11.
10
Surgical excision of basal cell carcinoma with complete margin control: outcome at 5-year follow-up.基底细胞癌的完整边缘控制外科切除:5 年随访结果。
Dermatology. 2010;220(4):363-9. doi: 10.1159/000300116. Epub 2010 May 13.

引用本文的文献

1
Intraoperative margin assessment for basal cell carcinoma with deep learning and histologic tumor mapping to surgical site.利用深度学习和组织学肿瘤定位到手术部位对基底细胞癌进行术中切缘评估。
NPJ Precis Oncol. 2024 Jan 3;8(1):2. doi: 10.1038/s41698-023-00477-7.
2
Superficial high-dose-rate brachytherapy for primary tumors and relapses after surgery in patients with basal cell carcinoma of the head and neck region: results of a retrospective comparative cohort study.头颈部基底细胞癌患者原发性肿瘤及术后复发的浅表高剂量率近距离放射治疗:一项回顾性比较队列研究的结果
J Contemp Brachytherapy. 2022 Oct;14(5):438-445. doi: 10.5114/jcb.2022.121134. Epub 2022 Nov 14.
3
Management of Pre-malignant and Malignant Non-melanoma Skin Cancers: A Study from a Tertiary Care Hospital of North India.
北印度一家三级护理医院对癌前和恶性非黑色素瘤皮肤癌的管理:一项研究
J Cutan Aesthet Surg. 2022 Apr-Jun;15(2):118-123. doi: 10.4103/JCAS.JCAS_241_20.
4
Does reduction of the oncologic safety margin for facial basal cell carcinoma result in higher recurrence rates?面部基底细胞癌肿瘤学安全切缘的缩小会导致更高的复发率吗?
Arch Craniofac Surg. 2021 Jun;22(3):135-140. doi: 10.7181/acfs.2021.00206. Epub 2021 Jun 25.
5
When is a surgical multidisciplinary approach required in the management of head and neck non-melanoma skin cancer and in advanced head and neck pathologies involving skin?在头颈部非黑色素瘤皮肤癌的管理以及涉及皮肤的晚期头颈部病变中,何时需要采取外科多学科治疗方法?
Acta Otorhinolaryngol Ital. 2021 Apr;41(Suppl. 1):S145-S157. doi: 10.14639/0392-100X-suppl.1-41-2021-15.
6
Treatment of Non-melanoma Skin Cancers in the Absence of Mohs Micrographic Surgery.无莫氏显微外科手术情况下的非黑色素瘤皮肤癌治疗
Plast Reconstr Surg Glob Open. 2020 Dec 22;8(12):e3300. doi: 10.1097/GOX.0000000000003300. eCollection 2020 Dec.
7
Basal cell carcinoma with compromised margins: retrospective study of management, evolution, and prognosis.基底细胞癌伴边缘侵犯:治疗、演变和预后的回顾性研究。
An Bras Dermatol. 2021 Jan-Feb;96(1):17-26. doi: 10.1016/j.abd.2020.11.001. Epub 2020 Nov 20.
8
Basal Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches.基底细胞癌:从病理生理学到新型治疗方法
Biomedicines. 2020 Oct 23;8(11):449. doi: 10.3390/biomedicines8110449.
9
Photoacoustic imaging for three-dimensional visualization and delineation of basal cell carcinoma in patients.用于患者基底细胞癌三维可视化和描绘的光声成像。
Photoacoustics. 2020 May 5;18:100187. doi: 10.1016/j.pacs.2020.100187. eCollection 2020 Jun.
10
Computer-assisted diagnosis techniques (dermoscopy and spectroscopy-based) for diagnosing skin cancer in adults.用于诊断成人皮肤癌的计算机辅助诊断技术(基于皮肤镜检查和光谱学)。
Cochrane Database Syst Rev. 2018 Dec 4;12(12):CD013186. doi: 10.1002/14651858.CD013186.